Literature DB >> 20345343

Drug-membrane interactions: significance for medicinal chemistry.

M Lúcio1, J L F C Lima, S Reis.   

Abstract

Generally drugs can act on the level of different biological membranes as well as inside the cells that are limited by membranes. Even in the latter situation, drugs must still interact with the membrane in order to cross it and reach their targets. For this reason, the efficiency of drugs to interact with the membranes constitutes one of the most important pharmacological features playing an essential role in their biological activity. Membranes are the gathering place of many proteins and lipids, and are the structures where most cellular activities occur. Although drugs bind to proteins and regulate their activity, the membrane lipid phase is no less important. Great part of compounds studied induces structural changes in the lipid phase resulting structural defects, which in turn disturb membrane function and indirectly modulate membrane proteins. This paper reviews the clinical significance of drug-membrane interaction studies with a special focus in the lipidic components of the membrane and reinforcing the importance of these studies in the field of medicinal chemistry since they constitute stimulating opportunities for understanding drugs mode of action and toxic effects and cannot be overlooked during drug design and synthesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20345343     DOI: 10.2174/092986710791111233

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  26 in total

Review 1.  Lipid simulations: a perspective on lipids in action.

Authors:  Ilpo Vattulainen; Tomasz Rog
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-04-01       Impact factor: 10.005

2.  Cellular membrane phospholipids act as a depository for quaternary amine containing drugs thus competing with the acetylcholine/nicotinic receptor.

Authors:  Damon Barbacci; Shelley N Jackson; Ludovic Muller; Thomas Egan; Ernest K Lewis; J Albert Schultz; Amina S Woods
Journal:  J Proteome Res       Date:  2012-04-30       Impact factor: 4.466

3.  Cholesterol and lipid phases influence the interactions between serotonin receptor agonists and lipid bilayers.

Authors:  Rebecca Batchelor; Christopher J Windle; Sébastien Buchoux; Mark Lorch
Journal:  J Biol Chem       Date:  2010-10-20       Impact factor: 5.157

4.  Drug resistance in breast cancer cells: biophysical characterization of and doxorubicin interactions with membrane lipids.

Authors:  Chiranjeevi Peetla; Radhika Bhave; Sivakumar Vijayaraghavalu; Andrew Stine; Edgar Kooijman; Vinod Labhasetwar
Journal:  Mol Pharm       Date:  2010-11-11       Impact factor: 4.939

5.  A biophysical approach to daunorubicin interaction with model membranes: relevance for the drug's biological activity.

Authors:  Ana Catarina Alves; Daniela Ribeiro; Miguel Horta; José L F C Lima; Cláudia Nunes; Salette Reis
Journal:  J R Soc Interface       Date:  2017-08       Impact factor: 4.118

6.  In vitro assessment of NSAIDs-membrane interactions: significance for pharmacological actions.

Authors:  Cláudia Nunes; Daniela Lopes; Marina Pinheiro; Catarina Pereira-Leite; Salette Reis
Journal:  Pharm Res       Date:  2013-05-24       Impact factor: 4.200

7.  The application of solid-state NMR spectroscopy to study candesartan cilexetil (TCV-116) membrane interactions. Comparative study with the AT1R antagonist drug olmesartan.

Authors:  Dimitrios Ntountaniotis; Tahsin Kellici; Andreas Tzakos; Pinelopi Kolokotroni; Theodore Tselios; Johanna Becker-Baldus; Clemens Glaubitz; Sonyan Lin; Alexandros Makriyannis; Thomas Mavromoustakos
Journal:  Biochim Biophys Acta       Date:  2014-06-16

Review 8.  The Role of Protein-Protein and Protein-Membrane Interactions on P450 Function.

Authors:  Emily E Scott; C Roland Wolf; Michal Otyepka; Sara C Humphreys; James R Reed; Colin J Henderson; Lesley A McLaughlin; Markéta Paloncýová; Veronika Navrátilová; Karel Berka; Pavel Anzenbacher; Upendra P Dahal; Carlo Barnaba; James A Brozik; Jeffrey P Jones; D Fernando Estrada; Jennifer S Laurence; Ji Won Park; Wayne L Backes
Journal:  Drug Metab Dispos       Date:  2016-02-05       Impact factor: 3.922

9.  Lipid Nanosystems and Serum Protein as Biomimetic Interfaces: Predicting the Biodistribution of a Caffeic Acid-Based Antioxidant.

Authors:  Eduarda Fernandes; Sofia Benfeito; Fernando Cagide; Hugo Gonçalves; Sigrid Bernstorff; Jana B Nieder; M Elisabete Cd Real Oliveira; Fernanda Borges; Marlene Lúcio
Journal:  Nanotechnol Sci Appl       Date:  2021-02-09

10.  A Biophysical Insight of Camptothecin Biodistribution: Towards a Molecular Understanding of Its Pharmacokinetic Issues.

Authors:  Andreia Almeida; Eduarda Fernandes; Bruno Sarmento; Marlene Lúcio
Journal:  Pharmaceutics       Date:  2021-06-12       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.